-
2
-
-
0035835412
-
Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in rat brain following intraperitoneal injection: Application of a new solid-phase extraction LC-APcI-MS-MS-isotope dilution method
-
DOI 10.1016/S0378-4347(00)00442-4, PII S0378434700004424
-
Barker SA, Littlefield-Chabaud MA, and David C (2001) Distribution of the hallucinogens N,N-dimethyltryptamine and 5-methoxy-N,N-dimethyltryptamine in rat brain following intraperitoneal injection: application of a new solid-phase extraction LC-APcI-MS-MS-isotope dilution method. J Chromatogr B Biomed Sci Appl 751:37-47. (Pubitemid 32146312)
-
(2001)
Journal of Chromatography B: Biomedical Sciences and Applications
, vol.751
, Issue.1
, pp. 37-47
-
-
Barker, S.A.1
Littlefield-Chabaud, M.A.2
David, C.3
-
3
-
-
70350330871
-
Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4- Methylenedioxymethamphetamine in the rat
-
Baumann MH, Zolkowska D, Kim I, Scheidweiler KB, Rothman RB, and Huestis MA (2009) Effects of dose and route of administration on pharmacokinetics of (+ or -)-3,4- methylenedioxymethamphetamine in the rat. Drug Metab Dispos 37:2163-2170.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 2163-2170
-
-
Baumann, M.H.1
Zolkowska, D.2
Kim, I.3
Scheidweiler, K.B.4
Rothman, R.B.5
Huestis, M.A.6
-
4
-
-
0013804235
-
5-Methoxy-N,N-dimethyltryptamine, a possible endogenous psychotoxin
-
Benington F, Morin RD, and Clark LC Jr (1965) 5-Methoxy-N,N- dimethyltryptamine, a possible endogenous psychotoxin. Ala J Med Sci 2:397-403.
-
(1965)
Ala J Med Sci
, vol.2
, pp. 397-403
-
-
Benington, F.1
Morin, R.D.2
Clark Jr., L.C.3
-
5
-
-
7944239256
-
An analytical perspective on favoured synthetic routes to the psychoactive tryptamines
-
Brandt SD, Freeman S, McGagh P, Abdul-Halim N, and Alder JF (2004) An analytical perspective on favoured synthetic routes to the psychoactive tryptamines. J Pharm Biomed Anal 36:675-691.
-
(2004)
J Pharm Biomed Anal
, vol.36
, pp. 675-691
-
-
Brandt, S.D.1
Freeman, S.2
McGagh, P.3
Abdul-Halim, N.4
Alder, J.F.5
-
6
-
-
2942532123
-
Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances
-
DOI 10.1081/CLT-120030949
-
Brush DE, Bird SB, and Boyer EW (2004) Monoamine oxidase inhibitor poisoning resulting from Internet misinformation on illicit substances. J Toxicol Clin Toxicol 42:191-195. (Pubitemid 38758532)
-
(2004)
Journal of Toxicology - Clinical Toxicology
, vol.42
, Issue.2
, pp. 191-195
-
-
Brush, D.E.1
Bird, S.B.2
Boyer, E.W.3
-
7
-
-
33747684131
-
A demand for clarity regarding a case report on the ingestion of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation
-
author reply 407
-
Callaway JC, Grob CS, McKenna DJ, Nichols DE, Shulgin A, and Tupper KW (2006) A demand for clarity regarding a case report on the ingestion of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) in an Ayahuasca preparation. J Anal Toxicol 30:406-407; author reply 407.
-
(2006)
J Anal Toxicol
, vol.30
, pp. 406-407
-
-
Callaway, J.C.1
Grob, C.S.2
McKenna, D.J.3
Nichols, D.E.4
Shulgin, A.5
Tupper, K.W.6
-
8
-
-
0035213861
-
The CYP2D6 humanized mouse: Effect of the human CYP2D6 transgene and HNF4α on the disposition of debrisoquine in the mouse
-
Corchero J, Granvil CP, Akiyama TE, Hayhurst GP, Pimprale S, Feigenbaum L, Idle JR, and Gonzalez FJ (2001) The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4α on the disposition of debrisoquine in the mouse. Mol Pharmacol 60:1260-1267. (Pubitemid 33144897)
-
(2001)
Molecular Pharmacology
, vol.60
, Issue.6
, pp. 1260-1267
-
-
Corchero, J.1
Granvil, C.P.2
Akiyama, T.E.3
Hayhurst, G.P.4
Pimprale, S.5
Feigenbaum, L.6
Idle, J.R.7
Gonzalez, F.J.8
-
9
-
-
0027275566
-
Physiological parameters in laboratory animals and humans
-
DOI 10.1023/A:1018943613122
-
Davies B and Morris T (1993) Physiological parameters in laboratory animals and humans. Pharm Res 10:1093-1095. (Pubitemid 23211439)
-
(1993)
Pharmaceutical Research
, vol.10
, Issue.7
, pp. 1093-1095
-
-
Davies, B.1
Morris, T.2
-
10
-
-
0033967676
-
Non-linear pharmacokinetics of MDMA ('ecstasy') in humans
-
de la Torre R, Farré M, Ortuño J, Mas M, Brenneisen R, Roset PN, Segura J, and Camí J (2000) Non-linear pharmacokinetics of MDMA ('ecstasy') in humans. Br J Clin Pharmacol 49:104-109.
-
(2000)
Br J Clin Pharmacol
, vol.49
, pp. 104-109
-
-
De La Torre, R.1
Farré, M.2
Ortuño, J.3
Mas, M.4
Brenneisen, R.5
Roset, P.N.6
Segura, J.7
Camí, J.8
-
11
-
-
0017169690
-
5-Methoxy-N,N-dimethyltryptamine: Behavioral and toxicological effects in animals
-
Gillin JC, Tinklenberg J, Stoff DM, Stillman R, Shortlidge JS, and Wyatt RJ (1976) 5-Methoxy-N,N-dimethyltryptamine: behavioral and toxicological effects in animals. Biol Psychiatry 11:355-358.
-
(1976)
Biol Psychiatry
, vol.11
, pp. 355-358
-
-
Gillin, J.C.1
Tinklenberg, J.2
Stoff, D.M.3
Stillman, R.4
Shortlidge, J.S.5
Wyatt, R.J.6
-
12
-
-
0018703895
-
Serotonin receptor binding affinities of tryptamine analogues
-
DOI 10.1021/jm00190a014
-
Glennon RA and Gessner PK (1979) Serotonin receptor binding affinities of tryptamine analogues. J Med Chem 22:428-432. (Pubitemid 10229331)
-
(1979)
Journal of Medicinal Chemistry
, vol.22
, Issue.4
, pp. 428-432
-
-
Glennon, R.A.1
Gessner, P.K.2
-
14
-
-
54049111358
-
Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors
-
Halberstadt AL, Buell MR, Masten VL, Risbrough VB, and Geyer MA (2008) Modification of the effects of 5-methoxy-N,N-dimethyltryptamine on exploratory behavior in rats by monoamine oxidase inhibitors. Psychopharmacology (Berl) 201:55-66.
-
(2008)
Psychopharmacology (Berl)
, vol.201
, pp. 55-66
-
-
Halberstadt, A.L.1
Buell, M.R.2
Masten, V.L.3
Risbrough, V.B.4
Geyer, M.A.5
-
15
-
-
79951893032
-
Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models
-
Jiang XL, Gonzalez FJ, and Yu AM (2011) Drug-metabolizing enzyme, transporter, and nuclear receptor genetically modified mouse models. Drug Metab Rev 43:27-40.
-
(2011)
Drug Metab Rev
, vol.43
, pp. 27-40
-
-
Jiang, X.L.1
Gonzalez, F.J.2
Yu, A.M.3
-
17
-
-
79251469423
-
A pharmacokinetic model for evaluating the impact of hepatic and intestinal first-pass loss of saquinavir in the rat
-
Lledó-García R, Nácher A, Casabó VG, and Merino-Sanjuán M (2010) A pharmacokinetic model for evaluating the impact of hepatic and intestinal first-pass loss of saquinavir in the rat. Drug Metab Dispos 39:294-301.
-
(2010)
Drug Metab Dispos
, vol.39
, pp. 294-301
-
-
Lledó-García, R.1
Nácher, A.2
Casabó, V.G.3
Merino-Sanjuán, M.4
-
18
-
-
79959431447
-
Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine
-
doi:10.1002/bmc.1551
-
McIlhenny EH, Riba J, Barbanoj MJ, Strassman R, and Barker SA (2011) Methodology for and the determination of the major constituents and metabolites of the Amazonian botanical medicine ayahuasca in human urine. Biomed Chromatogr doi:10.1002/bmc.1551.
-
(2011)
Biomed Chromatogr
-
-
McIlhenny, E.H.1
Riba, J.2
Barbanoj, M.J.3
Strassman, R.4
Barker, S.A.5
-
19
-
-
2542476021
-
Clinical investigations of the therapeutic potential of ayahuasca: Rationale and regulatory challenges
-
McKenna DJ (2004) Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacol Ther 102:111-129.
-
(2004)
Pharmacol Ther
, vol.102
, pp. 111-129
-
-
McKenna, D.J.1
-
20
-
-
52649087879
-
Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses
-
Mueller M, Peters FT, Maurer HH, McCann UD, and Ricaurte GA (2008) Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") and its major metabolites in squirrel monkeys at plasma concentrations of MDMA that develop after typical psychoactive doses. J Pharmacol Exp Ther 327:38-44.
-
(2008)
J Pharmacol Exp Ther
, vol.327
, pp. 38-44
-
-
Mueller, M.1
Peters, F.T.2
Maurer, H.H.3
McCann, U.D.4
Ricaurte, G.A.5
-
21
-
-
0035686702
-
Pharmepéna-Psychonautics: Human intranasal, sublingual and oral pharmacology of 5-methoxy-N,N-dimethyl-tryptamine
-
Ott J (2001) Pharmepéna-Psychonautics: human intranasal, sublingual and oral pharmacology of 5-methoxy-N,N-dimethyl-tryptamine. J Psychoactive Drugs 33:403-407.
-
(2001)
J Psychoactive Drugs
, vol.33
, pp. 403-407
-
-
Ott, J.1
-
22
-
-
0029161453
-
Use of quantitative modelling in methylene chloride risk assessment
-
Rhomberg L (1995) Use of quantitative modelling in methylene chloride risk assessment. Toxicology 102:95-114.
-
(1995)
Toxicology
, vol.102
, pp. 95-114
-
-
Rhomberg, L.1
-
23
-
-
0030582460
-
Localization of monoamine oxidases in human peripheral tissues
-
Saura J, Nadal E, van den Berg B, Vila M, Bombi JA, and Mahy N (1996) Localization of monoamine oxidases in human peripheral tissues. Life Sci 59:1341-1349.
-
(1996)
Life Sci
, vol.59
, pp. 1341-1349
-
-
Saura, J.1
Nadal, E.2
Van Den Berg, B.3
Vila, M.4
Bombi, J.A.5
Mahy, N.6
-
24
-
-
79952354609
-
Psychedelic 5-methoxy-N,N- Dimethyltryptamine: Metabolism, pharmacokinetics, drug interactions, and pharmacological actions
-
Shen HW, Jiang XL, Winter JC, and Yu AM (2010a) Psychedelic 5-methoxy-N,N- dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Curr Drug Metab 11:659-666.
-
(2010)
Curr Drug Metab
, vol.11
, pp. 659-666
-
-
Shen, H.W.1
Jiang, X.L.2
Winter, J.C.3
Yu, A.M.4
-
25
-
-
77952291461
-
Development of a LC-MS/MS method to analyze 5-methoxy-N,N- dimethyltryptamine and bufotenine, and application to pharmacokinetic study
-
Shen HW, Jiang XL, and Yu AM (2009) Development of a LC-MS/MS method to analyze 5-methoxy-N,N-dimethyltryptamine and bufotenine, and application to pharmacokinetic study. Bioanalysis 1:87-95.
-
(2009)
Bioanalysis
, vol.1
, pp. 87-95
-
-
Shen, H.W.1
Jiang, X.L.2
Yu, A.M.3
-
26
-
-
77952293605
-
Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics
-
Shen HW, Wu C, Jiang XL, and Yu AM (2010b) Effects of monoamine oxidase inhibitor and cytochrome P450 2D6 status on 5-methoxy-N,N-dimethyltryptamine metabolism and pharmacokinetics. Biochem Pharmacol 80:122-128.
-
(2010)
Biochem Pharmacol
, vol.80
, pp. 122-128
-
-
Shen, H.W.1
Wu, C.2
Jiang, X.L.3
Yu, A.M.4
-
27
-
-
0023272620
-
Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N- Dimethyltryptamine and their N-oxides in the rat
-
DOI 10.1016/0006-2952(87)90159-6
-
Sitaram BR, Lockett L, Blackman GL, and McLeod WR (1987a) Urinary excretion of 5-methoxy-N,N-dimethyltryptamine, N,N-dimethyltryptamine and their N-oxides in the rat. Biochem Pharmacol 36:2235-2237. (Pubitemid 17101743)
-
(1987)
Biochemical Pharmacology
, vol.36
, Issue.13
, pp. 2235-2237
-
-
Sitaram, B.R.1
Lockett, L.2
Blackman, G.L.3
McLeod, W.R.4
-
28
-
-
0023177599
-
In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat
-
DOI 10.1016/0006-2952(87)90118-3
-
Sitaram BR, Lockett L, Talomsin R, Blackman GL, and McLeod WR (1987b) In vivo metabolism of 5-methoxy-N,N-dimethyltryptamine and N,N-dimethyltryptamine in the rat. Biochem Pharmacol 36:1509-1512. (Pubitemid 17079563)
-
(1987)
Biochemical Pharmacology
, vol.36
, Issue.9
, pp. 1509-1512
-
-
Sitaram, B.R.1
Lockett, L.2
Talomsin, R.3
-
29
-
-
0025222924
-
Observations on the metabolism of the psychotomimetic indolealkylamines: Implications for future clinical studies
-
Sitaram BR and McLeod WR (1990) Observations on the metabolism of the psychotomimetic indolealkylamines: implications for future clinical studies. Biol Psychiatry 28:841-848.
-
(1990)
Biol Psychiatry
, vol.28
, pp. 841-848
-
-
Sitaram, B.R.1
McLeod, W.R.2
-
30
-
-
29144529744
-
A fatal intoxication following the ingestion of 5-methoxy-N,N- Dimethyltryptamine in an ayahuasca preparation
-
Sklerov J, Levine B, Moore KA, King T, and Fowler D (2005) A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. J Anal Toxicol 29:838-841. (Pubitemid 41803388)
-
(2005)
Journal of Analytical Toxicology
, vol.29
, Issue.8
, pp. 838-841
-
-
Sklerov, J.1
Levine, B.2
Moore, K.A.3
King, T.4
Fowler, D.5
-
31
-
-
0016424425
-
Evidence that 5-methoxy-N,N-dimethyl tryptamine is a specific substrate for MAO-A in the rat: Implications for the indoleamine dependent behavioural syndrome
-
Squires RF (1975) Evidence that 5-methoxy-N,N-dimethyl tryptamine is a specific substrate for MAO-A in the rat: implications for the indoleamine dependent behavioural syndrome. J Neurochem 24:47-50.
-
(1975)
J Neurochem
, vol.24
, pp. 47-50
-
-
Squires, R.F.1
-
32
-
-
0019457705
-
Characterization of eight biogenic indoleamines as substrates for type A and type B monoamine oxidase
-
DOI 10.1016/0006-2952(81)90320-8
-
Suzuki O, Katsumata Y, and Oya M (1981) Characterization of eight biogenic indoleamines as substrates for type A and type B monoamine oxidase. Biochem Pharmacol 30:1353-1358. (Pubitemid 11035402)
-
(1981)
Biochemical Pharmacology
, vol.30
, Issue.11
, pp. 1353-1358
-
-
Suzuki, O.1
Katsumata, Y.2
Oya, M.3
-
33
-
-
0023074730
-
Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain
-
Thorpe LW, Westlund KN, Kochersperger LM, Abell CW, and Denney RM (1987) Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain. J Histochem Cytochem 35:23-32. (Pubitemid 17221594)
-
(1987)
Journal of Histochemistry and Cytochemistry
, vol.35
, Issue.1
, pp. 23-32
-
-
Thorpe, L.W.1
Westlund, K.N.2
Kochersperger, L.M.3
-
34
-
-
61449202932
-
An inhibitory metabolite leads to dose- And time-dependent pharmacokinetics of (R)-N-{1-[3-(4-ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido[2,3- d]pyrimidin-2- yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)- acetamide (AMG 487) in human subjects after multiple dosing
-
Tonn GR, Wong SG, Wong SC, Johnson MG, Ma J, Cho R, Floren LC, Kersey K, Berry K, Marcus AP, et al. (2009) An inhibitory metabolite leads to dose- and time-dependent pharmacokinetics of (R)-N-{1-[3-(4-ethoxy-phenyl)-4-oxo-3,4- dihydro-pyrido[2,3-d]pyrimidin-2- yl]-ethyl}-N-pyridin-3-yl-methyl-2-(4- trifluoromethoxy-phenyl)-acetamide (AMG 487) in human subjects after multiple dosing. Drug Metab Dispos 37:502-513.
-
(2009)
Drug Metab Dispos
, vol.37
, pp. 502-513
-
-
Tonn, G.R.1
Wong, S.G.2
Wong, S.C.3
Johnson, M.G.4
Ma, J.5
Cho, R.6
Floren, L.C.7
Kersey, K.8
Berry, K.9
Marcus, A.P.10
-
35
-
-
0033970783
-
The paradox of 5-methoxy-N,N-dimethyltryptamine: An indoleamine hallucinogen that induces stimulus control via 5-HT(1A) receptors
-
DOI 10.1016/S0091-3057(99)00178-1, PII S0091305799001781
-
Winter JC, Filipink RA, Timineri D, Helsley SE, and Rabin RA (2000) The paradox of 5-methoxy-N,N-dimethyltryptamine: an indoleamine hallucinogen that induces stimulus control via 5-HT1A receptors. Pharmacol Biochem Behav 65:75-82. (Pubitemid 30017998)
-
(2000)
Pharmacology Biochemistry and Behavior
, vol.65
, Issue.1
, pp. 75-82
-
-
Winter, J.C.1
Filipink, R.A.2
Timineri, D.3
Helsley, S.E.4
Rabin, R.A.5
-
36
-
-
53849113961
-
Indolealkylamines: Biotransformations and potential drug-drug interactions
-
Yu AM (2008) Indolealkylamines: biotransformations and potential drug-drug interactions. AAPS J 10:242-253.
-
(2008)
AAPS J
, vol.10
, pp. 242-253
-
-
Yu, A.M.1
-
37
-
-
0038240578
-
Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase
-
DOI 10.1097/00008571-200306000-00002
-
Yu AM, Idle JR, Herraiz T, Küpfer A, and Gonzalez FJ (2003a) Screening for endogenous substrates reveals that CYP2D6 is a 5-methoxyindolethylamine O-demethylase. Pharmacogenetics 13:307-319. (Pubitemid 36724524)
-
(2003)
Pharmacogenetics
, vol.13
, Issue.6
, pp. 307-319
-
-
Yu, A.-M.1
Idle, J.R.2
Herraiz, T.3
Kupfer, A.4
Gonzalez, F.J.5
-
38
-
-
0037310739
-
The relative contribution of monoamine oxidase and cytochrome P450 lsozymes to the metabolic deamination of the trace amine tryptamine
-
DOI 10.1124/jpet.102.043786
-
Yu AM, Granvil CP, Haining RL, Krausz KW, Corchero J, Küpfer A, Idle JR, and Gonzalez FJ (2003b) The relative contribution of monoamine oxidase and cytochrome P450 isozymes to the metabolic deamination of the trace amine tryptamine. J Pharmacol Exp Ther 304:539-546. (Pubitemid 36152328)
-
(2003)
Journal of Pharmacology and Experimental Therapeutics
, vol.304
, Issue.2
, pp. 539-546
-
-
Yu, A.-M.1
Granvil, C.P.2
Haining, R.L.3
Krausz, K.W.4
Corchero, J.5
Kupfer, A.6
Idle, J.R.7
Gonzalez, F.J.8
|